{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:12:23Z","timestamp":1788541943125,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","award":["CDRI\/IEC\/2022\/A11"],"award-info":[{"award-number":["CDRI\/IEC\/2022\/A11"]}],"id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"National Scientific and Technical Research Council","doi-asserted-by":"publisher","award":["PIP 2021\\u20132023 11220200101045CO"],"award-info":[{"award-number":["PIP 2021\\u20132023 11220200101045CO"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"National Scientific and Technical Research Council","doi-asserted-by":"publisher","award":["PIP 2021\\u20132023 11220200102910CO"],"award-info":[{"award-number":["PIP 2021\\u20132023 11220200102910CO"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009573","name":"National University of Rosario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2021-I-A-00512"],"award-info":[{"award-number":["PICT 2021-I-A-00512"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/P027989\/1"],"award-info":[{"award-number":["MR\/P027989\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021778","name":"Agencia Nacional De Promoci\u00f3n Cient\u00edfica Y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejmech.2025.117630","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T11:23:49Z","timestamp":1744629829000},"page":"117630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Advancing N,N\u2032-disubstituted diamines in antimalarial drug development: Structure-activity relationships and mechanistic studies"],"prefix":"10.1016","volume":"291","author":[{"given":"Alejandro I.","family":"Recio-Balsells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Panozzo-Z\u00e9nere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Carlucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirupa","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashan","family":"Manhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes Bacelo","family":"Fioressi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina N.","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Arrizabalaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabana I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu L.","family":"Tekwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niti","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-1573","authenticated-orcid":false,"given":"Guillermo R.","family":"Labadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117630_bib1","series-title":"World Malaria Report 2024","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117630_bib2","year":"2021","journal-title":"Global Technical Strategy for Malaria 2016\u20132030, 2021 Update"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117630_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117630_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pt.2019.05.004","article-title":"Next-generation phenotypic screening in early drug discovery for infectious diseases","volume":"35","author":"Aulner","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2025.117630_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpddr.2022.11.001","article-title":"Current and emerging target identification methods for novel antimalarials","volume":"20","author":"Challis","year":"2022","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117630_bib7","doi-asserted-by":"crossref","DOI":"10.1017\/S0031182020000207","article-title":"Computational approaches for drug discovery against trypanosomatid-caused diseases","volume":"147","author":"Pereira","year":"2020","journal-title":"Parasitology"},{"issue":"48","key":"10.1016\/j.ejmech.2025.117630_bib8","doi-asserted-by":"crossref","first-page":"18746","DOI":"10.1074\/jbc.TM118.003342","article-title":"Polyamines in protozoan pathogens","volume":"293","author":"Phillips","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117630_bib9","first-page":"151","article-title":"Polyamine transport in parasites: a potential target for new antiparasitic drug development","volume":"140","author":"Reguera","year":"2005","journal-title":"Comp. Biochem. Physiol., Part C: Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117630_bib10","first-page":"44","article-title":"Polyamines: functions, metabolism, and role in human disease management","volume":"9","author":"Sagar","year":"2021","journal-title":"Med. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117630_bib11","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3390\/ijms23031284","article-title":"Role of eIF5A in mitochondrial function","volume":"23","author":"Barba-Aliaga","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"35","key":"10.1016\/j.ejmech.2025.117630_bib12","doi-asserted-by":"crossref","first-page":"27045","DOI":"10.1074\/jbc.M110.122275","article-title":"Glutathione reductase-null malaria parasites have normal blood stage growth but arrest during development in the mosquito","volume":"285","author":"Pastrana-Mena","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.ejmech.2025.117630_bib13","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.2174\/0929867325666180926151059","article-title":"The thiol-polyamine metabolism of trypanosoma cruzi: molecular targets and drug repurposing strategies","volume":"26","author":"Talevi","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117630_bib14","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1021\/jm900187v","article-title":"Recent advances in the development of polyamine analogues as antitumor agents","volume":"52","author":"Casero","year":"2009","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2025.117630_bib15","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1042\/BCJ20160383","article-title":"Targeting polyamine metabolism for cancer therapy and prevention","volume":"473","author":"Murray-Stewart","year":"2016","journal-title":"Biochem. J."},{"issue":"4467","key":"10.1016\/j.ejmech.2025.117630_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.6775372","article-title":"Polyamine metabolism: a potential therapeutic target in trypanosomes","volume":"210","author":"Bacchi","year":"1980","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117630_bib17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1073\/pnas.86.2.651","article-title":"Bis(benzyl)polyamine analogs inhibit the growth of chloroquine-resistant human malaria parasites (Plasmodium falciparum) in vitro and in combination with alpha-difluoromethylornithine cure murine malaria","volume":"86","author":"Bitonti","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117630_bib18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0021-9258(19)40241-X","article-title":"Bis(benzyl)polyamine analogs as novel substrates for polyamine oxidase","volume":"265","author":"Bitonti","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.117630_bib19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1128\/AAC.35.7.1403","article-title":"Suppression of Leishmania donovani by oral administration of a bis(benzyl)polyamine analog","volume":"35","author":"Baumann","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117630_bib20","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1128\/AAC.34.8.1485","article-title":"Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase","volume":"34","author":"Bitonti","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117630_bib21","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.bmcl.2006.03.048","article-title":"Novel alkylpolyaminoguanidines and alkylpolyaminobiguanides with potent antitrypanosomal activity","volume":"16","author":"Bi","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117630_bib22","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/S0968-0896(97)00157-0","article-title":"Polyamine derivatives as inhibitors of trypanothione reductase and assessment of their trypanocidal activities","volume":"5","author":"O'Sullivan","year":"1997","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117630_bib23","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/AAC.00106-13","article-title":"Anthracene-polyamine conjugates inhibit in vitro proliferation of intraerythrocytic Plasmodium falciparum parasites","volume":"57","author":"Niemand","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117630_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.01.083","article-title":"Targeting polyamine transport in Trypanosoma cruzi","volume":"147","author":"Reigada","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117630_bib25","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ejmech.2017.11.069","article-title":"A minimalistic approach to develop new anti-apicomplexa polyamines analogs","volume":"143","author":"Panozzo-Z\u00e9nere","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117630_bib26","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.bmcl.2011.12.101","article-title":"Synthesis and antikinetoplastid activity of a series of N,N\u2032-Substituted diamines","volume":"22","author":"Caminos","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117630_bib27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1080\/17460441.2019.1660642","article-title":"Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery","volume":"14","author":"Lucas","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117630_bib28","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2174\/1568026033452096","article-title":"The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery","volume":"3","author":"Lin","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117630_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd3367","article-title":"Probing the links between in vitro potency, ADMET and physicochemical parameters","volume":"10","author":"Gleeson","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117630_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117630_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117630_bib32","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117630_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/17425255.2021.1865309","article-title":"Analyzing FDA-Approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols?","author":"Pathania","year":"2021","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117630_bib34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.copbio.2007.10.005","article-title":"Drug discovery beyond the \u2018rule-of-five.\u2019","volume":"18","author":"Zhang","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117630_bib35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/ci034243x","article-title":"ESOL: estimating aqueous solubility directly from molecular structure","volume":"44","author":"Delaney","year":"2004","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117630_bib36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/jac\/dkp449","article-title":"In vitro selection of Plasmodium falciparum drug-resistant parasite lines","volume":"65","author":"Nzila","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117630_bib37","first-page":"390","article-title":"Evaluation of the sensitivity in vitro of Plasmodium falciparum and in vivo of Plasmodium chabaudi malaria to various drugs and their combinations","volume":"52","author":"Rahman","year":"1997","journal-title":"Med. J. Malaysia"},{"issue":"17","key":"10.1016\/j.ejmech.2025.117630_bib38","doi-asserted-by":"crossref","first-page":"9389","DOI":"10.1073\/pnas.94.17.9389","article-title":"Variations in frequencies of drug resistance in Plasmodium falciparum","volume":"94","author":"Rathod","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117630_bib39","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1021\/acsinfecdis.8b00113","article-title":"Evaluation of current and emerging antimalarial medicines for inhibition of Toxoplasma gondii growth in vitro","volume":"4","author":"Radke","year":"2018","journal-title":"ACS Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117630_bib40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12964-023-01373-0","article-title":"Polyamines: their significance for maintaining health and contributing to diseases","volume":"21","author":"Xuan","year":"2023","journal-title":"Cell Commun. Signal."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117630_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial drug discovery: efficacy models for compound screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117630_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmech.2018.11.021","article-title":"Substituted aminoquinoline-pyrimidine hybrids: synthesis, in vitro antimalarial activity evaluation and docking studies","volume":"162","author":"Maurya","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117630_bib43","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/1087057107310638","article-title":"Growth, drug susceptibility, and gene expression profiling of Plasmodium falciparum cultured in medium supplemented with human serum","volume":"12","author":"Singh","year":"2007","journal-title":"SLAS Discov"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117630_bib44","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Martin","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"51","key":"10.1016\/j.ejmech.2025.117630_bib45","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1021\/acs.biochem.7b00964","article-title":"Investigating pharmacological targeting of G-quadruplexes in the human malaria parasite","volume":"56","author":"Anas","year":"2017","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.ejmech.2025.117630_bib46","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1128\/aem.57.7.2101-2103.1991","article-title":"Cytotoxicity of T-2 toxin and its metabolites determined with the neutral red cell viability assay","volume":"57","author":"Babich","year":"1991","journal-title":"Appl. Environ. Microbiol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:47:20Z","timestamp":1778042840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425003952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":45,"alternative-id":["S0223523425003952"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117630","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing N,N\u2032-disubstituted diamines in antimalarial drug development: Structure-activity relationships and mechanistic studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117630"}}